Source recordFED

ANIS, Aslam H

Federal grants & contributions· Canadian Institutes of Health Research· FY2013· $115,284· BC

Description

The impact of price-caps on the generic pharmaceutical industry and provincial drug plan costs in Canada

Amendment chain · 1 entry

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.

$115,284$0Original · 2012-04-01 (start date) · total $115,284
  • #02012-04-01$115,284
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2012-04-01(start date)$115,284—The impact of price-caps on the generic pharmaceutical industry and provincial drug plan costs in Canada

Related records · 1

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (exact legal name match; no business number on file)

RefDepartment · programCurrent valueFY
236-2013-2014-Q4-00329Canadian Institutes of Health Research | Instituts de recherche en santé du Canada$22,750,000FY2015

Cite as: Glassbox record view · Federal grants & contributions · 236-2011-2012-Q4-00142 · retrieved 2026-11-12.